/ /

  • linkedin
  • Increase Font
  • Sharebar

    Cataract surgery 2016: News from the pharmaceutical front

     

    Medical treatment for presbyopia

    While the huge amount of research that is ongoing to develop novel implant solutions for presbyopia correction is exciting and promising, Dr. Osher cited the idea of topical drop therapy as an interesting approach that could provide an option for risk averse individuals to reduce spectacle dependence. The concept originated by the late Lee Nordan, MD, is known as Liquid Vision and is being developed by Presbyopia Therapies. Intended for binocular use, it combines aceclidine to create miosis and tropicamide to inhibit accommodation. Together the two medications provide a pinhole effect for increased depth of focus without the accommodative blur that occurs using a miotic by itself.

    “Well-respected cataract surgeons who have been involved with this project are very enthusiastic about its potential,” noted Dr. Osher.

     

    Eric D. Donnenfeld, MD

    E: [email protected]

    Dr. Donnenfeld is a consultant to Abbott Medical Optics, AcuFocus, Alcon, Allergan, Aquesys, Bausch + Lomb, Beaver Visitec International, CRST, Glaukos, Novaliq, Omeros, Pfizer, and Shire Pharmaceuticals. He consults and has investment interests in Katena, Novabay Pharmaceuticals, PRN Pharmaceuticals, and RPS Diagnostics.

     

    Robert H. Osher, MD

    E: [email protected]

    Dr. Osher is a consultant to Alcon Laboratories, Bausch + Lomb, Beaver Visitec International, Carl Zeiss Meditec, Clarity Medical Systems, MicroSurgical Technology, Omeros, and the Video Journal of Cataract and Refractive Surgery.

     

    Mark Packer, MD  

    E: [email protected]

    Dr. Packer is a consultant to Advanced Vision Science, Alcon, Allergan, Bausch + Lomb, Cassini BV, International Biomedical Devices, LensAR, Rayner, and STAAR Surgical, and he owns equity in Cassini BV, International Biomedical Devices, LensAR, and TrueVision.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results